EUVIMEDEUVIMED entdecken
Crossref

Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study

Johanna Diekmann, Jonas Neuser, Manuel Röhrich, Thorsten Derlin, Carolin Zwadlo, Tobias Koenig, Desiree Weiberg, Felix Jäckle, Tibor Kempf, Tobias L Ross, Jochen Tillmanns, James T Thackeray und 4 weitere

Journal of Nuclear Medicine · 2023-08 · 64 (8) · 1279-1286

DOI: 10.2967/jnumed.122.265147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 08.06.2023. Verfasst von Johanna Diekmann und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany; diekmann.johanna@mh-hannover.de. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Hypertension. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using multimodal imaging, we investigated the extent and functional correlates of myocardial fibroblast activation in patients with aortic stenosis (AS) scheduled for transcatheter aortic valve replacement (TAVR). AS may cause myocardial fibrosis, which is associated with disease progression and may limit response to TAVR. Novel radiopharmaceuticals identify upregulation of fibroblast activation protein (FAP) as a cellular substrate of cardiac profibrotic activity.

Methods

Twenty-three AS patients underwent 68Ga-FAP inhibitor 46 (68Ga-FAPI) PET, cardiac MRI, and echocardiography within 1-3 d before TAVR. Imaging parameters were correlated and then were integrated with clinical and blood biomarkers. Control cohorts of subjects without a history of cardiac disease and with (n = 5) and without (n = 9) arterial hypertension were compared with matched AS subgroups.

Results

Myocardial FAP volume varied significantly among AS subjects (range, 1.54-138 cm3, mean ± SD, 42.2 ± 35.6 cm3) and was significantly higher than in controls with (7.42 ± 8.56 cm3, P = 0.007) and without (2.90 ± 6.67 cm3; P < 0.001) hypertension. FAP volume correlated with N-terminal prohormone of brain natriuretic peptide (r = 0.58, P = 0.005), left ventricular ejection fraction (r = -0.58, P = 0.02), mass (r = 0.47, P = 0.03), and global longitudinal strain (r = 0.55, P = 0.01) but not with cardiac MRI T1 (spin-lattice relaxation time) and extracellular volume (P = not statistically significant). In-hospital improvement in left ventricular ejection fraction after TAVR correlated with pre-TAVR FAP volume (r = 0.440, P = 0.035), N-terminal prohormone of brain natriuretic peptide, and strain but not with other imaging parameters.

Conclusion

FAP-targeted PET identifies varying degrees of left ventricular fibroblast activation in TAVR candidates with advanced AS. 68Ga-FAPI signal does not match other imaging parameters, generating the hypothesis that it may become useful as a tool for personalized selection of optimal TAVR candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve StenosisHypertensionHumansPilot ProjectsStroke VolumeVentricular Function, LeftGallium RadioisotopesNatriuretic Peptide, BrainTreatment OutcomeMolecular ImagingFibroblastsAortic Valve

Stichwörter der Autor:innen

PETaortic stenosisfibroblast activation proteinmolecular imagingmyocardial fibrosis

Substanzen

Gallium RadioisotopesNatriuretic Peptide, Brain

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany; diekmann.johanna@mh-hannover.de.
  • Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany; and.
  • Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.

Zitieren

APA

Diekmann, J., Neuser, J., Röhrich, M., Derlin, T., Zwadlo, C., Koenig, T., Weiberg, D., Jäckle, F., Kempf, T., Ross, T. L., Tillmanns, J., Thackeray, J. T., Widder, J., Haberkorn, U., Bauersachs, J., & Bengel, F. M. (2023). Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study. Journal of Nuclear Medicine, 64(8), 1279-1286. https://doi.org/10.2967/jnumed.122.265147

Vancouver

Diekmann J, Neuser J, Röhrich M, Derlin T, Zwadlo C, Koenig T, et al. Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study. Journal of Nuclear Medicine. 2023;64(8):1279-1286. doi:10.2967/jnumed.122.265147

BibTeX
@article{Diekmann2023,
  author = {Diekmann, Johanna and Neuser, Jonas and Röhrich, Manuel and Derlin, Thorsten and Zwadlo, Carolin and Koenig, Tobias and Weiberg, Desiree and Jäckle, Felix and Kempf, Tibor and Ross, Tobias L and Tillmanns, Jochen and Thackeray, James T and Widder, Julian and Haberkorn, Uwe and Bauersachs, Johann and Bengel, Frank M},
  title = {Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  volume = {64},
  number = {8},
  pages = {1279--1286},
  doi = {10.2967/jnumed.122.265147}
}
Kostenlos starten →